Back
Fate Therapeutics Vs. Ocular Therapeutix Industry Stock Comparison
Sell
24
FATE
Fate Therapeutics
Last Price:
4.08
Seasonality Move:
-2.97%
Sell
40
OCUL
Ocular Therapeutix
Last Price:
5.03
Seasonality Move:
-9.99%
Sell
24
Fate Therapeutics (FATE)
is a Sell
Is Fate Therapeutics a Buy, Sell or Hold?
- The current Fate Therapeutics [FATE] share price is $3.95. The Score for FATE is 24, which is 52% below its historic median score of 50, and infers higher risk than normal.
- FATE is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Sell
40
Ocular Therapeutix (OCUL)
is a Sell
Is Ocular Therapeutix a Buy, Sell or Hold?
- The current Ocular Therapeutix [OCUL] share price is $4.74. The Score for OCUL is 40, which is 20% below its historic median score of 50, and infers higher risk than normal.
- OCUL is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
FATE Stock Price Chart
What is Fate Therapeutics's stock price today?
-
The Fate Therapeutics share price today is $3.95
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FATE is experiencing slight selling pressure.
OCUL Stock Price Chart
What is Ocular Therapeutix's stock price today?
-
The Ocular Therapeutix share price today is $4.74
Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and OCUL is experiencing slight selling pressure.
FATE Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -0.77 | Sell |
| Relative Strength Index (14 RSI): | 23.81 | Sell |
| Chaikin Money Flow: | -1996012 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
OCUL Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | -1.11 | Sell |
| Relative Strength Index (14 RSI): | 25.27 | Sell |
| Chaikin Money Flow: | -703215 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | ( - ) | Buy |
| Bollinger Bands (100): | ( - ) | Buy |
FATE Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.26 | Sell |
| 20-day SMA: | 5.39 | Sell |
| 50-day SMA: | 6.52 | Sell |
| 200-day SMA: | 4.07 | Sell |
| 8-day EMA: | 4.31 | Sell |
| 20-day EMA: | 5.13 | Sell |
| 50-day EMA: | 5.77 | Sell |
| 200-day EMA: | 5.73 | Sell |
OCUL Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 4.8 | Sell |
| 20-day SMA: | 6.66 | Sell |
| 50-day SMA: | 8.43 | Sell |
| 200-day SMA: | 4.92 | Sell |
| 8-day EMA: | 5.11 | Sell |
| 20-day EMA: | 6.29 | Sell |
| 50-day EMA: | 7.11 | Sell |
| 200-day EMA: | 5.78 | Sell |
Fate Therapeutics Earnings Growth & FATE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.07 per share, an increase next quarter of $0.05 per share, a decrease this year of $0.15 per share, and an increase next year of $0.20 per share.
Ocular Therapeutix Earnings Growth & OCUL Earnings Dates
- Analysts estimate an earnings increase this quarter of $0.08 per share, an increase next quarter of $0.07 per share, an increase this year of $0.25 per share, and an increase next year of $0.15 per share.
Fate Therapeutics Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
Ocular Therapeutix Technical Analysis
| Apr 18 | Apr 19 | Apr 22 | Apr 23 | Apr 24 | Apr 25 | Apr 26 | Apr 29 | Apr 30 | May 1 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Apr | ||||||||||
| 18 | 19 | 22 | 23 | 24 | 25 | 26 | 29 | 30 | 01 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||